Free tool
FAERS Monitor: Amiodarone Hydrochloride
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021594 or its brand name (Amiodarone Hydrochloride, Amiodarone Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
9,185
Serious
7,993
87% of reports
Hospitalization
4,599
Death reported
1,582
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea997
- off label use869
- asthenia835
- fatigue770
- drug ineffective688
- product use in unapproved indication648
- nausea545
- cough528
- dizziness471
- atrial fibrillation465
- pneumonia449
- vomiting439
- drug interaction417
- hypotension417
- condition aggravated407
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 59 |
| 2005 | 106 |
| 2006 | 83 |
| 2007 | 68 |
| 2008 | 41 |
| 2009 | 108 |
| 2010 | 119 |
| 2011 | 140 |
| 2012 | 332 |
| 2013 | 144 |
| 2014 | 142 |
| 2015 | 157 |
| 2016 | 179 |
| 2017 | 492 |
| 2018 | 479 |
| 2019 | 596 |
| 2020 | 592 |
| 2021 | 833 |
| 2022 | 916 |
| 2023 | 916 |
| 2024 | 1,042 |
| 2025 | 1,033 |
| 2026 | 606 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,974 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| atrial fibrillationSignal | 465 | 11.0 | 10.0 | 4,208 |
| drug interactionSignal | 417 | 6.0 | 5.5 | 1,754 |
| product use in unapproved indicationSignal | 648 | 6.0 | 5.6 | 2,720 |
| astheniaSignal | 835 | 5.1 | 4.8 | 2,787 |
| hypotensionSignal | 417 | 4.8 | 4.3 | 1,247 |
| coughSignal | 528 | 4.3 | 4.0 | 1,358 |
| dyspnoeaSignal | 997 | 4.0 | 3.8 | 2,335 |
| pneumoniaSignal | 449 | 3.2 | 2.9 | 678 |
| condition aggravatedSignal | 407 | 3.1 | 2.8 | 573 |
| off label useSignal | 869 | 2.3 | 2.1 | 645 |
| fatigueSignal | 770 | 2.3 | 2.1 | 564 |
| dizzinessSignal | 471 | 2.2 | 2.0 | 300 |
| vomitingSignal | 439 | 2.1 | 2.0 | 271 |
| nausea | 545 | 1.6 | 1.5 | 119 |
| drug ineffective | 688 | 1.2 | 1.1 | 23 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.